Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of Mosliciguat in PH-ILD
Sponsor: Pulmovant, Inc.
Summary
This is a Phase 2, randomized, double-blind, placebo-controlled, multi-center clinical study to evaluate the safety and efficacy of inhaled mosliciguat in participants with pulmonary hypertension associated with interstitial lung disease (PH-ILD).
Official title: A Phase 2, Randomized, Placebo-Controlled Trial to Assess the Efficacy and Safety of Mosliciguat in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease
Key Details
Gender
All
Age Range
18 Years - 85 Years
Study Type
INTERVENTIONAL
Enrollment
135
Start Date
2024-10-29
Completion Date
2028-01
Last Updated
2026-09-10
Healthy Volunteers
No
Conditions
Interventions
Mosliciguat
Dose level 1, 2, or 3 for inhalation
Dry Powder Inhaler
Dry powder inhaler for mosliciguat or placebo delivery
Placebo
Matching placebo for inhalation
Locations (85)
Clinical Research Site
Phoenix, Arizona, United States
Clinical Research Site
Los Angeles, California, United States
Clinical Research Site
Sacramento, California, United States
Clinical Research Site
Santa Barbara, California, United States
Clinical Research Site
Torrance, California, United States
Clinical Research Site
Washington D.C., District of Columbia, United States
Clinical Research Site
Celebration, Florida, United States
Clinical Research Site
Chicago, Illinois, United States
Clinical Research Site
Iowa City, Iowa, United States
Clinical Research Site
Kansas City, Kansas, United States
Clinical Research Site
Louisville, Kentucky, United States
Clinical Research Site
Boston, Massachusetts, United States
Clinical Research Site
Boston, Massachusetts, United States
Clinical Research Site
New York, New York, United States
Clinical Research Site
New York, New York, United States
Clinical Research Site
Durham, North Carolina, United States
Clinical Research Site
Greensboro, North Carolina, United States
Clinical Research Site
Cincinnati, Ohio, United States
Clinical Research Site
Bend, Oregon, United States
Clinical Research Site
Philadelphia, Pennsylvania, United States
Clinical Research Site
East Providence, Rhode Island, United States
Clinical Research Site
Charleston, South Carolina, United States
Clinical Research Site
Dallas, Texas, United States
Clinical Research Site
Houston, Texas, United States
Clinical Research Site
Salt Lake City, Utah, United States
Clinical Research Site
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
Clinical Research Site
Santa Fe, Argentina
Clinical Research Site
Sydney, New South Wales, Australia
Clinical Research Site
Westmead, New South Wales, Australia
Clinical Research Site
Auchenflower, Queensland, Australia
Clinical Research Site
Brussels, Brussels Capital, Belgium
Clinical Research Site
Leuven, Flanders, Belgium
Clinical Research Site
Porto Alegre, Rio Grande do Sul, Brazil
Clinical Research Site
Blumenau, Santa Catarina, Brazil
Clinical Research Site
São Paulo, Brazil
Clinical Research Site
São Paulo, Brazil
Clinical Research Site
Calgary, Alberta, Canada
Clinical Research Site
London, Ontario, Canada
Clinical Research Site
Toronto, Ontario, Canada
Clinical Research Site
Prague, Prague, Czechia
Clinical Research Site
Prague, Prague, Czechia
Clinical Research Site
Bron, Auvergne-Rhône-Alpes, France
Clinical Research Site
Saint-Priest-en-Jarez, Auvergne-Rhône-Alpes, France
Clinical Research Site
Strasbourg, Bas-Rhin, France
Clinical Research Site
Le Kremlin-Bicêtre, Île-de-France Region, France
Clinical Research Site
Heidelberg, Baden-Wurttemberg, Germany
Clinical Research Site
München, Bavaria, Germany
Clinical Research Site
Dresden, Saxony, Germany
Clinical Research Site
Halle, Saxony-Anhalt, Germany
Clinical Research Site
Genova, Genoa, Italy
Clinical Research Site
Pavia, Lombardy, Italy
Clinical Research Site
Naples, Italy
Clinical Research Site
Palermo, Italy
Clinical Research Site
Roma, Italy
Clinical Research Site
Narashino, Chiba, Japan
Clinical Research Site
Sapporo, Hokkaido, Japan
Clinical Research Site
Kobe, Hyōgo, Japan
Clinical Research Site
Yokohama, Kanagawa, Japan
Clinical Research Site
Okayama, Okayama-ken, Japan
Clinical Research Site
Suita, Osaka, Japan
Clinical Research Site
Chiyoda City, Tokyo, Japan
Clinical Research Site
Riga, Latvia
Clinical Research Site
Mexico City, Mexico City, Mexico
Clinical Research Site
Nijmegen, Gelderland, Netherlands
Clinical Research Site
Amsterdam, North Holland, Netherlands
Clinical Research Site
Christchurch, Canterbury, New Zealand
Clinical Research Site
Hamilton, Waikato Region, New Zealand
Clinical Research Site
Poznan, Greater Poland Voivodeship, Poland
Clinical Research Site
Lodz, Lódzkie, Poland
Clinical Research Site
Otwock, Masovian Voivodeship, Poland
Clinical Research Site
Incheon, Incheon Gwang'yeogsi [Inch'on-Kwangyokshi], South Korea
Clinical Research Site
Dongjak, Seoul Teugbyeolsi [Seoul-T'ukpyolshi], South Korea
Clinical Research Site
Seoul, Seoul Teugbyeolsi [Seoul-T'ukpyolshi], South Korea
Clinical Research Site
Seoul, Seoul-Teukbyeolsi, South Korea
Clinical Research Site
Santander, Cantabria, Spain
Clinical Research Site
Marbella, Málaga, Spain
Clinical Research Site
Madrid, Spain
Clinical Research Site
Toledo, Spain
Clinical Research Site
Pendik, Istanbul, Turkey (Türkiye)
Clinical Research Site
Bornova, İzmir, Turkey (Türkiye)
Clinical Research Site
Cambridge, England, United Kingdom
Clinical Research Site
London, England, United Kingdom
Clinical Research Site
London, England, United Kingdom
Clinical Research Site
London, England, United Kingdom
Clinical Research Site
Clydebank, Scotland, United Kingdom